The event of an tailored vaccine is a part of the corporate’s customary process for brand new variants, BioNTech, which makes vaccines along with Pfizer (PFE.N), mentioned in an announcement.
“The primary steps of growing a possible new vaccine overlap with the analysis obligatory with a purpose to consider whether or not a brand new shot will probably be wanted,” it added.
The Omicron variant carries a really excessive international danger of surges, the WHO warned on Monday as extra international locations reported instances, prompting border closures
BioNTech had mentioned on Friday it expects extra lab information over the following two weeks to assist decide if there may be want for an Omicron-specific vaccine. Rival Moderna (MRNA.O) has mentioned it was engaged on a redesign of its COVID-19 vaccine for future booster photographs.